NCT06979518: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Pulmonary Disease, Chronic Obstructive